TrialHuman brain mapping2016

Predicting beneficial effects of atomoxetine and citalopram on response inhibition in Parkinson's disease with clinical and neuroimaging measures.

Zheng Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.